<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03746158</url>
  </required_header>
  <id_info>
    <org_study_id>2018-4937</org_study_id>
    <nct_id>NCT03746158</nct_id>
  </id_info>
  <brief_title>Interindividual Variation in Excretion of Curcumin</brief_title>
  <official_title>University of Massachusetts Amherst</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Massachusetts, Amherst</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University of Massachusetts, Amherst</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this project is to elucidate the interindividual variations in excretion of
      curcumin and its metabolites.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">December 1, 2018</start_date>
  <completion_date type="Anticipated">April 1, 2019</completion_date>
  <primary_completion_date type="Anticipated">February 1, 2019</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Determine the concentration of curcumin and its metabolites in the human fecal samples.</measure>
    <time_frame>3-4 weeks</time_frame>
    <description>Utilize LC-MSMS to identify and quantify the curcumin and its metabolites in the subjects fecal samples.</description>
  </primary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">12</enrollment>
  <condition>Metabolites</condition>
  <condition>Gut Microbiota</condition>
  <arm_group>
    <arm_group_label>Curcumin</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>subjects will be assigned to consume one capsule of curcumin (330 mg of curcumin per capsule) three times a day (one capsule with each meal).</description>
  </arm_group>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>curcumin</intervention_name>
    <description>subjects will be assigned to consume one capsule of curcumin (330 mg of curcumin per capsule) three times a day (one capsule with each meal).</description>
    <arm_group_label>Curcumin</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  18-30 year old healthy adults

        Exclusion Criteria:

          -  Exclusion criteria included those who are &lt;18 or &gt;30 years old, have a BMI of &lt;20 or
             &gt;29 kg/m2, have a weight change &gt;4.5 kg in the past 3 months, exceed exercise
             activities of a curcumin level over the past 3 months, have any diseases, especially
             intestinal disorders, had abnormal liver or kidney function tests. Those who smoke,
             consume more than two alcoholic drinks per day, use medication affecting gut
             microbiota profile (e.g., antibiotics and probiotics) in past three months will also
             be excluded.

          -  Additionally, this study excludes menopausal women, those using hormone-based
             contraceptives, those with abnormal menstrual cycles, and those who are pregnant,
             lactating or planning to become pregnant.
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>30 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Hang Xiao</last_name>
    <phone>4135452281</phone>
    <email>hangxiao@foodsci.umass.edu</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Zhengze Li</last_name>
    <phone>4135591102</phone>
    <email>zhengzeli@foodsci.umass.edu</email>
  </overall_contact_backup>
  <verification_date>November 2018</verification_date>
  <study_first_submitted>November 15, 2018</study_first_submitted>
  <study_first_submitted_qc>November 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">November 19, 2018</study_first_posted>
  <last_update_submitted>November 29, 2018</last_update_submitted>
  <last_update_submitted_qc>November 29, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">December 3, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <intervention_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Curcumin</mesh_term>
  </intervention_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

